These Numbers Could Change Investor Views For DraftKings Inc (NASDAQ: DKNG)

Currently, there are 496.34M common shares owned by the public and among those 477.80M shares have been available to trade.

The company’s stock has a 5-day price change of 13.07% and 5.65% over the past three months. DKNG shares are trading -0.44% year to date (YTD), with the 12-month market performance up to 15.08% higher. It has a 12-month low price of $28.69 and touched a high of $53.61 over the same period. DKNG has an average intraday trading volume of 10.78 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 15.55%, 19.88%, and 10.49% respectively.

Institutional ownership of DraftKings Inc (NASDAQ: DKNG) shares accounts for 83.05% of the company’s 496.34M shares outstanding.

It has a market capitalization of $38.07B and a beta (3y monthly) value of 1.64. The earnings-per-share (ttm) stands at -$0.82. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.74% over the week and 2.88% over the month.

Analysts forecast that DraftKings Inc (DKNG) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 2.25 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. Earnings per share for the fiscal year are expected to increase by 131.81%, and 325.92% over the next financial year.

Looking at the support for the DKNG, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on June 23, 2025, with the firm’s price target at $50. Bernstein coverage for the DraftKings Inc (DKNG) stock in a research note released on June 04, 2025 offered a Outperform rating with a price target of $46. BTIG Research was of a view on April 22, 2025 that the stock is Buy, while Susquehanna gave the stock Positive rating on January 08, 2025, issuing a price target of $56- $54. Mizuho on their part issued Outperform rating on October 18, 2024.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.